Home › Astrocytoma › Minnesota
Astrocytoma clinical trials in Minnesota
5 studies for Astrocytoma are looking for participants at sites in Minnesota.
Cities in Minnesota
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- Mercy Hospital, Coon Rapids
- Fairview Southdale Hospital, Edina
- Abbott-Northwestern Hospital, Minneapolis
- and 3 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT07215910GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07301268SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Mayo Clinic - Rochester, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05303519Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT07468136First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma
- Elizabeth C. Neil, MD, Minneapolis
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated May 1, 2026 · NCT07560865From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.